More from the blog
- About us
- Dementia info
- Living with dementia
- Our scientists
- Our supporters
There have been many stories in the media over the past few months about COVID-19 and dementia.
This Father’s Day I’ll be lacing up my trainers for Dad and dementia research, and here’s why.
Dementia is thought to affect around 850,000 people in the UK. Most people associate the condition with Alzheimer’s disease, the most common cause of dementia. But there are other diseases that can cause the symptoms of dementia – including frontotemporal dementia (FTD).
Have you heard the news about the partnership between Alzheimer’s Research UK and Tikiboo?
With social fundraising no longer an option, my new working from home environment meant that I had to find a different way to help, and that was to learn more about dementia.
Microscopic images reveal the hidden beauty around and within us. Dementia researchers get a unique view of the intricate but stunning workings of the brain. To showcase the fascinating insights being gained in dementia research, we ran our Science Image Competition again this year.
The COVID-19 Symptom Tracker app, developed by King’s College London, is joining forces with the UK’s largest health-based charities. The aim is to reach people most at risk of COVID-19, including those with pre-existing health conditions such as dementia, diabetes, heart disease and those over the age of 70.
You may take comfort in knowing that previous generations have found innovative ways to raise money for charity in the face of international crisis.
It’s been great to hear supporters viewing the postponement of their event as an opportunity to use the time to raise even more money for dementia research and smash their fundraising targets. It’s brilliant to know our supporters are finding a way to continue to support our work in these extraordinary times.
This latest data offers a glimmer of hope for gantenerumab. The decrease in protein levels has led the researchers and the pharmaceutical company Roche to now invite the participants to take part in an open-label extension.
Although Alzheimer’s is the leading cause of dementia, vascular dementia affects 150,000 people in the UK, accounting for one in five of all dementia cases.
We hatched a plan to make sure that this year’s conference went ahead, but safely in light of the current coronavirus outbreak. It led to a huge social media effort to recreate the conference virtually on Twitter.
We’re thrilled to announce that we’re partnering with Alzheimer’s Research UK, one of the world’s leading dementia research charities dedicated to diagnosis, prevention, treatment and cure.
Amy Lloyd wins the 2020 award, which would ordinarily have been presented at our annual Research Conference that was due to take place in Wales this month.
People with dementia are likely to be particularly vulnerable to this virus so it is especially important that they and those around them take what steps they can to avoid transmission.
We’re acutely aware of the impact the outbreak will be having on people with dementia and their families, exacerbating an already unprecedented situation. Our hearts go out to everyone in such circumstances.
To mark Rare Disease Day we will discuss some of the rarer causes of dementia, providing information about what causes them and how they can be diagnosed.
Five years on from the national launch of Join Dementia Research, we look back at the service’s incredible impact and some of the exciting research taking place that you could get involved in.
The Early Detection of Neurodegenerative diseases (EDoN) initiative is spearheaded by Alzheimer’s Research UK and brings together 14 leading research and support organisations, working to develop innovative ways to pick up these diseases in the brain years before the symptoms of dementia start.
It’s a fantastic way to fundraise and engage your local community.
Primary progressive aphasia (PPA) is a condition caused by damage to parts of the brain that control our personality, emotions, language and behaviour.
It has certainly been a time of political turbulence. New governments bring new opportunities – and through its pledges, this one has given renewed hope to people affected by dementia. But we need more than hope: now we need action.
Most people know that smoking leads to poor health and a substantially increased risk of cancer and lung disease. But what’s the link to dementia?
This is our journey to a dementia diagnosis and illustrates why we need more research into quick and accurate diagnoses. It would’ve made such a difference to our lives.